1-Hydroxypyrene (1-OHP) | LC-MS/MS | Human Urine | 10-2000 pg/mL | N/A |
1; 2-Dihydroxybutyl Mercapturic Acid (DHBMA) | LC-MS/MS | Human Urine | 10-1000 ng/mL | N/A |
11-Dehydro Thromboxane B2 | LC-MS/MS | Human Urine | 25-2500 pg/mL | N/A |
11-Dehydro Thromboxane B2 | LC-MS/MS | Human Urine | 5-500 pg/mL | N/A |
17-Deactylnorgestimate; Levonorgestrel | LC-MS/MS | Human Plasma | 20-2500 pg/mL; 80-3500 pg/mL | EDTA |
2-Pralidoxime (2-PAM) | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | Heparin |
2,3 dinor Thromboxane-B2 (TXB2) | LC-MS/MS | Human Urine | 25-2500 pg/mL | N/A |
21-desacetyl Deflazacort | LC-MS/MS | Human Plasma | 1-200 ng/mL | EDTA |
3-Hydromorphone | LC-MS/MS | Human Plasma | 0.05000 - 10.00 ng/mL | EDTA |
3-Hydroxybenzo[a]pyrene (3-OH βaP) | LC-MS/MS | Human Urine | 25-600 fg/mL | N/A |
3-Hydroxyropylmercapturic Acid (3-HPMA) | LC-MS/MS | Human Urine | 35-5000 ng/mL | N/A |
5-Fluorocytosine | LC-MS/MS | Human Plasma | 0.5-100 ug/mL | EDTA |
5-Fluorouracil | LC-MS/MS | Human Plasma | 25-5000 ng/mL | EDTA |
6-Beta Naltrexol | LC-MS/MS | Human Plasma | 0.5-25 pg/mL | EDTA |
6-Mercaptopurine (6-MP) | LC-MS/MS | Human Plasma | 0.25-25 ng/mL | Heparin |
6-O-desmethyl Donepezil | LC-MS/MS | Human Plasma | 10-2000 pg/mL | EDTA |
8-iso-Prostaglandin F2 (Type III) | LC-MS/MS | Human Urine | 25-1500 pg/mL | N/A |
8-iso-Prostaglandin F2 (Type IV) | LC-MS/MS | Human Urine | 25-6000 pg/mL | N/A |
Abacavir; Zidovudine | LC-MS/MS | Human Plasma | 25-4000 ng/mL; 25-4000 ng/mL | Heparin |
Abacavir; Zidovudine; Lamivudine | LC-MS/MS | Human Plasma | 30-9000 ng/mL; 10-3000 ng/mL; 10-3000 ng/mL | EDTA |
Acetamidophenol | LC-MS/MS | Human Plasma | 0.5-25 ug/mL | Heparin, EDTA |
Acetaminophen | LC-MS/MS | Human Plasma | 50-10000 ng/mL | EDTA, Lithium Heparin |
Acetyl Salicylic Acid (ASA) | LC-MS/MS | Human Plasma | 0.1-20 ug/mL | EDTA |
Acetyl Salicylic Acid (ASA); Salicylic Acid (SA) | LC-MS/MS | Human Plasma | 2-500 ng/mL; 50-12500 ng/mL | NaF/EDTA |
Albuterol | LC-MS/MS | Human Plasma | 10-2000 pg/mL | K2 EDTA |
Alendronate | LC-MS/MS | Human Urine | 1-200 ng/mL | N/A |
Allopurinol; Oxypurinol | LC-MS/MS | Human Plasma | 0.1-20 ug/mL | EDTA |
Alprazolam; Alpha-Hydroxyalprazolam | LC-MS/MS | Human Plasma | 0.10-15 ng/mL; 0.05-7.5 ng/mL | K3 EDTA |
Amiodarone; Desethylamiodarone | LC-MS/MS | Human Plasma | 10-10000 ng/mL; 0.5-200 ng/mL | EDTA |
Amlodipine | LC-MS/MS | Human Serum | 50-10000 pg/mL | N/A |
Amlodipine | LC-MS/MS | Human Plasma | 50-10000 pg/mL | EDTA |
Amlodipine | LC-MS/MS | Human Plasma | .05-10 ng/mL | Heparin |
Amoxicillin | LC-MS/MS | Human Plasma | 0.1-30 ug/mL | EDTA |
Amphetamine D/L | LC-MS/MS | Human Plasma | 0.5-50 ng/mL | EDTA |
Amylin | EIA | Human Plasma | 5.94 – 60.0 pM | EDTA |
Anastrazole | LC-MS/MS | Human Plasma | 0.1-60 ng/mL | K3 EDTA, Lithium Heparin |
anti-KLH IgG | ELISA | Human Serum | .95-30.5 ng/mL | N/A |
anti-KLH IgM | ELISA | Human Serum | 31.3 - 1000 ng/mL | N/A |
anti-Pegfilgrastim ADA | EIA | Human Serum | N/A | N/A |
Aprepitant | LC-MS/MS | Human Plasma | 20-6000 ng/mL | EDTA |
Aromatic Amines (1-AMN; 2-AMN; 3-ABP; 4-ABP) | LC-MS/MS | Human Urine | 2-500 pg/mL; 2-500 pg/mL; .5-50 pg/mL; 1-100 pg/mL | N/A |
Atenolol | LC-MS/MS | Human Plasma | 5-1500 ng/mL | EDTA |
Atomoxetine | LC-MS/MS | Human Plasma | 5.2-1560 ng/mL | Heparin |
Atorvastatin; Parahydroxy Atorvastatin; Orthohydroxy Atorvastatin | LC-MS/MS | Human Plasma | 0.2-80 ng/mL; 0.1-40 ng/mL; 0.02-8 ng/mL | K2 and K3 EDTA |
Atropine | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | Heparin |
Baclofen | LC-MS/MS | Human Plasma | 2-500 ng/mL | EDTA |
Baclofen | LC-MS/MS | Mouse Plasma | 20-5000 ng/mL | Heparin |
Bicalutamide | LC-MS/MS | Human Plasma | 10-5000 ng/mL | K2 and K3 EDTA |
Budesonide | LC-MS/MS | Human Plasma | 5-1500 pg/mL | N/A |
Buprenorphine | LC-MS/MS | Human Plasma | 5-1000 pg/mL | Heparin |
Buprenorphine | LC-MS/MS | Human Plasma | 25-5000 pg/mL | Heparin |
Buprenorphine; Norbuprenorphine | LC-MS/MS | Human Plasma | 5-1000 pg/mL; 10-2000 pg/mL | Heparin |
Buprenorphine; Norbuprenorphine | LC-MS/MS | Human Plasma | 10-2500 pg/mL; 10-2500 pg/mL | Heparin |
Bupropion | LC-MS/MS | Human Plasma | 1-200 ng/mL | EDTA |
Bupropion; Hydroxybupropion | LC-MS/MS | Human Plasma | 1-400 ng/mL; 4-1600 ng/mL | EDTA |
C-Peptide | RIA | Human Serum | 0.05-4 ng/mL | N/A |
Cadmium | ICP/MS | Human Urine | 0.1-5 ng/mL | N/A |
Caffeine | LC-MS/MS | Human Plasma | 20-5000 ng/mL | Lithium Heparin |
Caffeine; Paraxanthine | LC-MS/MS | Human Plasma | 20-5000 ng/mL; 20-5000 ng/mL | Lithium Heparin |
Candesartan | LC-MS/MS | Human Plasma | 0.5-200 ng/mL | EDTA |
Candesartan | LC-MS/MS | Human Plasma | 2-200 ng/mL | EDTA |
Capsaicin | LC-MS/MS | Human Plasma | 5-500 pg/mL | Heparin |
Carboplatin | ICP/MS | Human Serum | 50-10000 ng/mL | N/A |
CD34+ | | Human Whole Blood | N/A | EDTA |
Celecoxib | LC-MS/MS | Human Plasma | 10-2500 ng/mL | EDTA |
CEMA; 2-HPMA; 3-HPMA; HBMA | LC-MS/MS | Human Urine | 20-5000 ng/mL; 2.50-2000 ng/mL; 20-5000 ng/mL; 0.2-150 ng/mL | N/A |
CEMA; 3-HPMA; HBMA | LC-MS/MS | Human Urine | 20-5000 ng/mL; 20-5000 ng/mL; 0.2-150 ng/mL | N/A |
Cetirizine | LC-MS/MS | Human Plasma | 10-750 ng/mL | EDTA |
Cetirizine | LC-MS/MS | Human Plasma | 2-400 ng/mL | EDTA |
Chlorpheniramine | LC-MS/MS | Human Plasma | 0.1-30 ng/mL | Heparin |
Cholecalciferol | LC-MS/MS | Human Plasma | 0.1-15 ng/mL | EDTA |
Cisplatin | ICP/MS | Human Serum | 50-10000 ng/mL | N/A |
CK 18 | ELISA | Human Serum | 75-1000 U/L | N/A |
Clarithromycin; 14-Hydroxy-Clarithromycin | LC-MS/MS | Human Plasma | 1-4000 ng/mL; 0.5-2000 ng/mL | EDTA |
Clavulanic Acid | LC-MS/MS | Human Plasma | 50-5000 ng/mL | EDTA |
Clonazepam | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | EDTA |
Clopidogrel; Clopidogrel Acid | LC-MS/MS | Human Plasma | 0.01-5 ng/mL; 10-5000 ng/mL | EDTA |
Codeine | LC-MS/MS | Human Plasma | 2-200 ng/mL; 0.1-30 ng/mL | Heparin |
COHb (Carboxyhemoglobin) | Spectrophotometric | Human Whole Blood | 1% - 5% | Sodium Heparin |
Colchicine | LC-MS/MS | Human Plasma | 0.03-10 ng/mL | EDTA |
Cortisol; 6-Beta-Hydroxycortisol | LC-MS/MS | Human Urine | 2-250 ng/mL; 25-1000 ng/mL | N/A |
Cotinine | LC-MS/MS | Human Saliva | 1-100 ng/mL | N/A |
Creatinine | ELISA | Human Urine | 30-600 ug/mL | N/A |
Creatinine | LC-MS/MS | Human Urine | 50-5000 ug/mL | N/A |
CyanoEthylValine (CEV-Hg adducts) | LC-MS/MS | Human Serum | 750-97500 pM | EDTA |
Cyclo (His-Pro) | LC-MS/MS | Human Plasma | 2.5-1000 ng/mL | EDTA |
Cyclosporine A | LC-MS/MS | Human Whole Blood | 5-1000 ng/mL | K2 EDTA |
Cyproterone Acetate; 15-Beta-Hydroxycyproterone Acetate | LC-MS/MS | Human Plasma | 0.1-40 ng/mL | Heparin |
Dabigatran Free | LC-MS/MS | Human Plasma | .5-250 ng/mL | EDTA |
Dabigatran Total | LC-MS/MS | Human Plasma | 1-500 ng/mL | EDTA |
Danazol | LC-MS/MS | Human Plasma | 0.5-200 ng/mL | K3 EDTA |
Danazol | LC-MS/MS | Human Serum | 0.5-250 ng/mL | N/A |
Dapagliflozin | LC-MS/MS | Human Plasma | .05-250 ng/mL | EDTA |
Darifenacin | LC-MS/MS | Human Plasma | 0.05-10 ng/mL | EDTA |
Deferiprone | LC-MS/MS | Human Serum | 0.1-20 ug/mL | N/A |
Desipramine | LC-MS/MS | Human Plasma | 0.5-200 ng/mL | Heparin |
Desipramine; 2-Hydroxydesipramine | LC-MS/MS | Human Plasma | .5-200 ng/mL; .25-100 ng/mL | Heparin |
Desmopressin | LC-MS/MS | Human Plasma | 0.5/2-250 pg/mL | EDTA |
Dexamethasone | LC-MS/MS | Human Plasma | 0.1-50 ng/mL | EDTA |
Dexlansoprazole | LC-MS/MS | Human Plasma | 20-4000 ng/mL | EDTA |
Dextromethorphan; Dextrorphan | LC-MS/MS | Rat Plasma | 2-1000 ng/mL; 25-5000 ng/mL | EDTA, Heparin |
Dextromethorphan; Dextrorphan | LC-MS/MS | Dog Plasma | 2-1000 ng/mL; 25-5000 ng/mL | EDTA |
Dextromethorphan; Dextrorphan | LC-MS/MS | Human Plasma | 0.2-200 ng/mL; 2.5-2500 ng/mL | Heparin |
Dextromethorphan; Dextrorphan | LC-MS/MS | Mouse Plasma | 2-1000 ng/mL; 25-5000 ng/mL | EDTA |
Dextromethorphan; Dextrorphan | LC-MS/MS | Human Plasma | 0.100-100 ng/mL; 0.2-200 ng/mL | Heparin |
Diazepam; Nordiazepam | LC-MS/MS | Human Plasma | 2-500 ng/mL | EDTA |
Diclofenac | LC-MS/MS | Human Plasma | 25-5000 pg/mL | K2 EDTA |
Diclofenac | LC-MS/MS | Human Plasma | 0.5-50 ng/mL | Heparin |
Diclofenac | LC-MS/MS | Human Plasma | 2.5-500 ng/mL | K2 EDTA |
Digoxin | LC-MS/MS | Human Plasma | 10-3500 pg/mL | K2 EDTA |
Dihydrotestosterone (DHT); Testosterone | LC-MS/MS | Human Serum | 10-2000 pg/mL; 50-10000 pg/mL | N/A |
Diltiazem; Deacetyldiltiazem; N-Desmethyldiltiazem | LC-MS/MS | Human Plasma | 2-100 ng/mL; 0.5-25 ng/mL | Heparin |
Diphenhydramine | LC-MS/MS | Human Plasma | 0.5-150 ng/mL | EDTA |
Dipyridamole | LC-MS/MS | Human Plasma | 10-3000 ng/mL | EDTA |
Dolasetron; Hydrodolasetron | LC-MS/MS | Human Plasma | 1-200 ng/mL | EDTA |
Donepezil | LC-MS/MS | Human Plasma | 0.3-45 ng/mL | Heparin |
Donepezil | LC-MS/MS | Human Plasma | 0.3-45 ng/mL | K2 EDTA |
Doxylamine | LC-MS/MS | Human Plasma | 0.2-100 ng/mL | K2 EDTA |
Dronedarone | LC-MS/MS | Human Plasma | 1-250 ng/mL | EDTA |
Drospirenone | LC-MS/MS | Human Plasma | 0.5-50 ng/mL | EDTA |
Duloxetine | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | Heparin |
Efavirenz | LC-MS/MS | Human Plasma | 10-5000 ng/mL | EDTA |
Emtricitabine | LC-MS/MS | Human Plasma | 10-2500 ng/mL | Heparin |
Enalapril; Enalaprilat | LC-MS/MS | Human Plasma | 0.5-100 ng/mL; 0.25-50 ng/mL | EDTA |
Eprosartan | LC-MS/MS | Human Plasma | 20-4000 ng/mL | EDTA |
Eptifibatide | LC-MS/MS | Human Plasma | 20-4000 ng/mL | EDTA |
Escitalopram | LC-MS/MS | Human Plasma | 0.2-40 ng/mL | K2 EDTA |
Estradiol | LC-MS/MS | Human Serum | 2.5-500 pg/mL | N/A |
Exemestane | LC-MS/MS | Human Plasma | 0.1-50 ng/mL | K3 EDTA |
Ezetimibe-Free | LC-MS/MS | Human Plasma | 0.05-10 ng/mL | EDTA |
Ezetimibe-Total | LC-MS/MS | Human Plasma | 0.5-100 ng/mL | EDTA |
Famotidine | LC-MS/MS | Human Plasma | 1-200 ng/mL | EDTA |
Febuxostat | LC-MS/MS | Human Plasma | 15-3000 ng/mL | Sodium Heparin |
Felodipine | LC-MS/MS | Human Plasma | 10-2000 pg/mL | EDTA |
Fenofibrate; Fenofibric Acid; Reduced Fenofibric Acid | LC-MS/MS | Human Plasma | 0.05-10 ng/mL; 10-2000 ng/mL; 0.5-100 ng/mL | EDTA |
Fentanyl | LC-MS/MS | Human Serum | 10-5000 pg/mL | N/A |
Fentanyl | LC-MS/MS | Rat Plasma | 20-7500 pg/mL | EDTA |
Fentanyl | LC-MS/MS | Rabbit Serum | 100-5000 pg/mL | N/A |
Fexofenadine | LC-MS/MS | Human Plasma | 2-400 ng/mL | Heparin |
FGF-21 | EIA | Human Serum | 60-3000 pg/mL | N/A |
Fimasartan | LC-MS/MS | Human Plasma | 2-500 ng/mL | K2 EDTA |
Fluoxetine; Duloxetine; Paroxetine; Sertraline | LC-MS/MS | Human Plasma | 1-500 ng/mL; 0.1-50 ng/mL; 0.2-100 ng/mL; 0.5-250 ng/mL | K2 EDTA |
Fluticasone | LC-MS/MS | Human Plasma | 1-150 pg/mL | K2 EDTA |
Fluvastatin | LC-MS/MS | Human Plasma | 1-400 ng/mL | K2 EDTA |
Fluvoxamine | LC-MS/MS | Human Plasma | 0.200-100ng/mL | EDTA |
Fremanezumab | ELISA | Human Plasma | 50-2000 ng/mL | K2 EDTA |
Furosemide | LC-MS/MS | Human Plasma | 0.1-20 ug/mL | EDTA |
Furosemide | LC-MS/MS | Human Urine | 0.1-20 ug/mL | N/A |
Gabapentin | LC-MS/MS | Human Plasma | 40-10000 ng/mL | K2 EDTA |
Galanthamine | LC-MS/MS | Human Plasma | 0.3-120 ng/mL | EDTA |
Gemcitabine; dFdU | LC-MS/MS | Human Plasma | 100-20000ng/mL; 247-49300 ng/mL | Heparin |
Gestodene | LC-MS/MS | Human Plasma | 50-10000 pg/mL | EDTA |
Ghrelin (total) | EIA | Human Plasma | 350-4000 pg/mL | K2 EDTA |
Ghrelin & Desacyl-Ghrelin | LC-MS/MS | Human Plasma | 50-2500 pg/mL | EDTA |
Glimepiride | LC-MS/MS | Human Plasma | 2-400 ng/mL | EDTA |
Glimepiride; Trans hydroxy Glimepiride | LC-MS/MS | Human Plasma | 1-200 ng/mL; 0.2-40 ng/mL | EDTA |
Glucagon | LC-MS/MS | Human Plasma | 100-10000 pg/mL | EDTA |
Glucagon | LC-MS/MS | Rat Plasma | 1-150 ng/mL | EDTA |
Glucagon | LC-MS/MS | Human Plasma | 2-200 ng/mL | EDTA |
Glucose | Enzyme Assay | Human Plasma | 60-1800 ug/mL | K3 EDTA |
Glyburide | LC-MS/MS | Human Plasma | 2-400 ng/mL | EDTA |
Glyburide; cis-3-Hydroxy Glyburide; trans-4-Hydroxy Glyburide | LC-MS/MS | Human Plasma | 0.5-200 ng/mL; 0.1-50 ng/mL | Heparin |
Glyburide; cis-3-Hydroxy Glyburide; trans-4-Hydroxy Glyburide | LC-MS/MS | Human Urine | 5-2500 ng/mL; 20-10000 ng/mL | N/A |
HEMA | LC-MS/MS | Human Urine | 0.1-20 ng/mL | N/A |
Hemoglobin | ELISA | Human Red Blood Cells | 2-16 mg/mL | EDTA |
Hydrochlorothiazide | LC-MS/MS | Human Plasma | 0.5-150 ng/mL | EDTA |
Hydrocodone | LC-MS/MS | Human Plasma | 0.1-40 ng/mL | Heparin |
Ibandronate | LC-MS/MS | Human Serum | 0.2-100 ng/mL | N/A |
Ibuprofen | LC-MS/MS | Human Plasma | 0.25-50 ug/mL | EDTA |
Ibuprofen | LC-MS/MS | Human Plasma | 0.5-50 ug/mL | Lithium Heparin |
IGF-1 | ELISA | Human Serum | .09-6 ng/mL | N/A |
Indapamide | LC-MS/MS | Human Whole Blood | 1-200 ng/mL | EDTA |
Indomethacin | LC-MS/MS | Human Plasma | 5-2500 ng/mL | K2 EDTA |
Insulin | EIA | Human Serum | 10 pM-400 pM | N/A |
Insulin | EIA | Human Serum | 20-600 pM | N/A |
Irbesartan | LC-MS/MS | Human Plasma | 30-6000 ng/mL | EDTA |
Isradipine | LC-MS/MS | Human Plasma | 50-10000 pg/mL | EDTA |
Itraconazole; 7-OH-Itraconazole | LC-MS/MS | Human Plasma | 1-500 ng/mL; 2-1000 ng/mL | K2 EDTA |
Ketoconazole | LC-MS/MS | Human Plasma | 20-4000 ng/mL | EDTA |
Ketoprofen | LC-MS/MS | Human Plasma | 0.25-50 ng/mL | EDTA, Heparin |
Lansoprazole | LC-MS/MS | Human Plasma | 2-1200 ng/mL | Heparin |
Lenalidomide | LC-MS/MS | Human Plasma | 5-1000 ng/mL | K2 EDTA |
Leptin | EIA | Human Plasma | 10-3200 pg/mL | EDTA |
Letrozole | LC-MS/MS | Human Plasma | 0.5-100 ng/mL | EDTA |
Levonorgestrel; Ethinyl Estradiol | LC-MS/MS | Human Plasma | 50-10000 pg/mL | EDTA |
Lisinopril | LC-MS/MS | Human Plasma | 0.5-100 ng/mL | K2 EDTA |
Lithium | ICP/MS | Human Serum | 50-10000 ng/mL | N/A |
Losartan; Losartan Acid Metabolite | LC-MS/MS | Human Plasma | 1-300 ng/mL | Sodium EDTA |
Lovastatin; Lovastatin Hydroxy-Acid | LC-MS/MS | Human Plasma | 0.1-20 ng/mL; 0.1-10 ng/mL | EDTA |
Lovastatin; Lovastatin Hydroxy-Acid | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | Heparin |
Malondialdehyde | EIA | Human Plasma | 20-500 ng/mL | K2 EDTA |
MCP-1 | EIA | Human Serum | 40-1500 pg/mL | N/A |
Mecamylamine | LC-MS/MS | Human Plasma | 1-100 ng/mL | EDTA |
Mesalamine | LC-MS/MS | Human Plasma | 3-1000 ng/mL | K2 EDTA |
Metaxalone | LC-MS/MS | Human Plasma | 25-5000 ng/mL | EDTA |
Metformin | LC-MS/MS | Human Plasma | 30-6000 ng/mL | EDTA |
Methadone: R-Methadone; S-Methadone | LC-MS/MS | Human Plasma | 20-4000 ng/mL | K2 EDTA |
Methotrexate | LC-MS/MS | Human Plasma | 2-400 ng/mL | K2 EDTA |
Methyl Salicylate | LC-MS/MS | Human Plasma | 1.75-50 ng/mL | Potassium Oxalate/Sodium Fluoride |
Methylphenidate | LC-MS/MS | Dog Plasma | 0.25-10 ng/mL | Heparin |
Methylphenidate | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | EDTA |
Methylphenidate-d; Methylphenidate-L | LC-MS/MS | Human Plasma | 0.5-50 ng/mL; 0.05-5 ng/mL | EDTA |
Methylphenidate-d; Ritalinic Acid-d; Methylphenidate-L; Ritalinic Acid-L | LC-MS/MS | Rat Plasma | 0.5-50 ng/mL; 5-500 ng/mL | Potassium Oxalate/ Sodium Fluoride |
Methylphenidate-d; Ritalinic Acid-d; Methylphenidate-L; Ritalinic Acid-L | LC-MS/MS | Mouse Plasma | 1-50 ng/mL; 5-500 ng/mL | Potassium Oxalate/Sodium Fluoride |
Methylprednisolone | LC-MS/MS | Dog Plasma | 0.5-50 ng/mL | EDTA |
Metoclopramide | LC-MS/MS | Human Plasma | 1-150 ng/mL | Heparin |
Metopropol | LC-MS/MS | Human Plasma | 1-400 ng/mL | K2 EDTA |
Metopropol | LC-MS/MS | Human Plasma | 1-500 ng/mL | K3 EDTA |
Midazolam; Hydroxymidazolam | LC-MS/MS | Human Plasma | .1-50 ng/mL | Heparin |
Midazolam; Hydroxymidazolam | LC-MS/MS | Human Plasma | 0.1-40 ng/mL; 0.1-20 ng/mL | Heparin |
Misoprostol Acid | LC-MS/MS | Human Plasma | 5-500 pg/mL | K2 EDTA |
Mometasone Furoate | LC-MS/MS | Human Plasma | 0.25-25 pg/mL | EDTA |
Monohydroxy-3-Butenyl Mercapturic Acid (MHBMA) | LC-MS/MS | Human Urine | 0.1-20 ng/mL | N/A |
Montelukast | LC-MS/MS | Human Plasma | 3-800 ng/mL | Heparin |
Morphine; Morphine-3-Glucuronide; Morphine-6-Glucuronide | LC-MS/MS | Human Serum | 0.5-50 ng/mL; 10-1000 ng/mL; 1-100 ng/mL | N/A |
Morphine; Morphine-3-Glucuronide; Morphine-6-Glucuronide | LC-MS/MS | Human Plasma | 0.25-50 ng/mL; 10-1000 ng/mL | EDTA |
Morphine; Morphine-6-Glucuronide | LC-MS/MS | Human Plasma | 0.25-50 ng/mL; 1-200 ng/mL | K3 EDTA |
Moxifloxacin | LC-MS/MS | Human Plasma | 0.5-50 ng/mL | Heparin |
NAB-Total; NAT-Total | LC-MS/MS | Human Urine | 2-200 pg/mL; 5-1000 pg/mL | N/A |
Naftifine | LC-MS/MS | Human Plasma | 1-200 ng/mL | K3 EDTA |
Nalbuphine | LC-MS/MS | Human Plasma | 0.5- 50 ng/mL | EDTA |
Naloxone | LC-MS/MS | Mouse Plasma | 0.5-100 ng/mL | Heparin |
Naloxone-3-Glucuronide | LC-MS/MS | Human Plasma | 75-15000 pg/mL | Heparin |
Naloxone-Free | LC-MS/MS | Human Plasma | 0.2-40 ng/mL | Heparin |
Naloxone-Total | LC-MS/MS | Human Plasma | 10-2000 pg/mL | EDTA |
Naltrexone | LC-MS/MS | Dog Plasma | 0.1-50 ng/mL | EDTA |
Naltrexone | LC-MS/MS | Human Serum | 0.1-50 ng/mL | N/A |
Naltrexone; 6-Beta-Naltrexol | LC-MS/MS | Human Plasma | 4-500 pg/mL; 4-1600 pg/mL | EDTA |
Naltrexone; 6-Beta-Naltrexol | LC-MS/MS | Human Serum | 10-2000 pg/mL | N/A |
Niacin; Nicotinamide; Nicotinuric Acid | LC-MS/MS | Human Plasma | 25-5000 ng/mL; 10-2000 ng/mL; 5-1000 ng/mL | EDTA |
Nicotine; Cotinine | LC-MS/MS | Human Serum | 0.5-50 ng/mL; 1-200 ng/mL | N/A |
Nicotine; Cotinine | LC-MS/MS | Human Plasma | 0.2-10 ng/mL; 1-100 ng/mL | EDTA |
Nicotine; Cotinine | LC-MS/MS | Human Plasma | 1-50 ng/mL; 1-100 ng/mL | EDTA |
Nicotine; Cotinine; trans-3'-Hydroxycotinine | LC-MS/MS | Human Plasma | 0.2-10 ng/mL; 1-100 ng/mL | EDTA, Heparin |
Nicotine; Cotinine; trans-3'-Hydroxycotinine | LC-MS/MS | Human Plasma | 1-50 ng/mL; 5-500 ng/mL; 5-500 ng/mL | EDTA |
Nicotine; Cotinine; trans-3'-Hydroxycotinine; Nicotine Glucuronide; Cotinine Glucuronide; trans-3'-Hydroxycotinine Glucuronide | LC-MS/MS | Human Urine | 10-1000 ng/mL; 10-1000 ng/mL; 10-1000 ng/mL; 10-1000 ng/mL; 20-2000 ng/mL; 50-5000 ng/mL | N/A |
Nicotine; Cotinine; trans-3'-Hydroxycotinine; Nicotine Glucuronide; Cotinine Glucuronide; trans-3'-Hydroxycotinine Glucuronide | LC-MS/MS | Human Urine | 50-5000 ng/mL; 50-5000 ng/mL; 50-5000 ng/mL; 50-5000 ng/mL; 200-20000 ng/mL; 200-20000 ng/mL | N/A |
NNAL-Total | LC-MS/MS | Human Urine | 5-2000 pg/mL | N/A |
NNN; NNAL | LC-MS/MS | Human Urine | 0.2-40 pg/mL; 5-2000 pg/mL | N/A |
Nordiazepam | LC-MS/MS | Human Plasma | 10-500 ng/mL | EDTA |
Norethindrone; Ethinyl Estradiol | LC-MS/MS | Human Plasma | 0.05-10 ng/mL | K2 EDTA |
Norgestimate; Deacetylnorgestimate | LC-MS/MS | Human Plasma | 20-2500 pg/mL | EDTA |
Norgestrel (Reported as Levonorgestrel) | LC-MS/MS | Human Plasma | 0.05-10 ng/mL | EDTA, Heparin |
o-Toluidine | LC-MS/MS | Human Urine | 20-1000 pg/mL | N/A |
Olmesartan | LC-MS/MS | Human Plasma | 2.5-500 ng/mL | EDTA |
Olmesartan | LC-MS/MS | Human Plasma | 2.5-1500 ng/mL | K3 EDTA |
Omeprazole | LC-MS/MS | Human Plasma | 10-2000 ng/mL | Sodium Heparin |
Omeprazole | LC-MS/MS | Human Plasma | 2-700 ng/mL | EDTA |
Omeprazole; 5-OH Omeprazole | LC-MS/MS | Human Plasma | 4-2000 ng/mL; 1-500 ng/mL | K2 EDTA |
Ondansetron | LC-MS/MS | Human Plasma | 0.5-100 ng/mL | EDTA |
Orlistat | LC-MS/MS | Human Plasma | 37.5-75000 pg/mL | EDTA |
Oxybutynin [R]; Oxybutynin [S]; Desethyloxybutynin [R]; Desethyloxybutynin [S] | LC-MS/MS | Rat Plasma | 1-250 ng/mL; 2.5-500 ng/mL | K2 EDTA |
Oxybutynin [R]; Oxybutynin [S]; Desethyloxybutynin [R]; Desethyloxybutynin [S] | LC-MS/MS | Human Plasma | 0.05-10 ng/mL | EDTA |
Oxybutynin; Desethyloxybutynin | LC-MS/MS | Human Plasma | 0.05-50 ng/mL | EDTA, Heparin |
Oxybutynin; Desethyloxybutynin | LC-MS/MS | Human Plasma | 0.05-10 ng/mL | K2 EDTA |
Oxycodone | LC-MS/MS | Human Plasma | 0.2-50 ng/mL | EDTA, Heparin |
Oxycodone; Noroxycodone | LC-MS/MS | Human Plasma | 0.5-100 ng/mL; 0.02 - 5.00 ng/mL | Sodium EDTA |
Oxycodone; Noroxycodone; Oxymorphone | LC-MS/MS | Human Plasma | .5-125 ng/mL; .2-50 ng/mL; .02-5 ng/mL | K2 EDTA |
Paclitaxel | LC-MS/MS | Human Plasma | 10-4000 ng/mL | K2 EDTA |
Paliperidone | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | K2 EDTA |
Pantoprazole | LC-MS/MS | Human Plasma | 20-6000 ng/mL | Heparin |
Paroxetine | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | Heparin |
Paroxetine | LC-MS/MS | Human Plasma | 0.1- 50 ng/mL | EDTA |
PEG-IFN alpha 2a (Pegasys) | EIA | Human Serum | 250-6000 pg/mL | N/A |
Phentermine | LC-MS/MS | Human Plasma | 0.25-50 ng/mL | EDTA |
Phenytoin | LC-MS/MS | Human Plasma | 20-5000 ng/mL | K3 EDTA |
Pitavistatin | LC-MS/MS | Human Plasma | 0.5-150 ng/mL | K2 EDTA |
Pitavistatin; Pitavastatin Lactone | LC-MS/MS | Human Plasma | .5-150 ng/mL | EDTA |
Pomalidomide | LC-MS/MS | Human Plasma | 1-100 ng/mL | K2 EDTA |
Pramipexole | LC-MS/MS | Human Plasma | 10-2000 pg/mL | K2 EDTA |
Pramipexole | LC-MS/MS | Human Plasma | 30-7500 pg/mL | K2 EDTA |
Pravastatin; 3-Alpha Hydroxy pravastatin; Pravastatin Lactone | LC-MS/MS | Human Urine | 0.2-100 ng/mL | N/A |
Pravastatin; 3-Alpha-Hydroxy Pravastatin; Pravastatin Lactone | LC-MS/MS | Human Plasma | 0.2-100 ng/mL | Heparin |
Pravastatin; Pravastatin Lactone | LC-MS/MS | Human Plasma | .2-100 ng/mL | K2 EDTA |
Prednisone; Prednisolone | LC-MS/MS | Human Plasma | 0.4-100 ng/mL; 4-1000 ng/mL | EDTA |
Progesterone | LC-MS/MS | Human Plasma | 0.05-15 ng/mL | EDTA |
Progesterone | LC-MS/MS | Human Serum | 0.05-15 ng/mL | N/A |
Promethazine | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | Heparin |
Propylene Glycol | LC-MS/MS | Human Urine | 250-25000 ng/mL | N/A |
Prostaglandin E2 (PGE-2) | EIA | Human Urine | 30-1500 pg/mL (STD curve 10-500 pg/mL, samples @ DF=3) | N/A |
Pseudoephedrine | LC-MS/MS | Human Plasma | 1-200 ng/mL | EDTA |
PTH 1-34 | ELISA | Human Plasma | 6-150 pg/mL | EDTA |
Quetiapine | LC-MS/MS | Human Plasma | 1-200 ng/mL | EDTA |
Quetiapine | LC-MS/MS | Human Plasma | 5-1000 ng/mL | EDTA |
Quinidine | HPLC/FL | Human Plasma | 0.05-10 ug/mL | Heparin |
Quinidine | HPLC/FL | Human Plasma | 2-250 ng/mL | Heparin |
R-Omeprazole; S-Omeprazole | LC-MS/MS | Human Plasma | 0.5-100 ng/mL | EDTA |
R-Warfarin; S-Warfarin | LC-MS/MS | Human Plasma | 12.5-2500 ng/mL | EDTA |
R-Warfarin; S-Warfarin | LC-MS/MS | Human Plasma | 12.5-2500 ng/mL | Sodium Heparin |
R-Warfarin; S-Warfarin | LC-MS/MS | Human Plasma | 1-200 ng/mL | EDTA |
Rabeprazole | LC-MS/MS | Human Plasma | 5-400 ng/mL | Heparin |
Raloxifene | LC-MS/MS | Human Plasma | 5-1000 pg/mL | Heparin |
Ramipril; Ramiprilat | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | EDTA |
Repaglinide | LC-MS/MS | Human Plasma | 0.3-75 ng/mL | EDTA |
Ribavirin | LC-MS/MS | Human Serum | 5-2000 ng/mL | N/A |
Ribavirin | LC-MS/MS | Human Red Blood Cells | 0.1-10 ug/mL | EDTA |
Ribavirin | LC-MS/MS | Human Plasma | 10-2000 ng/mL | EDTA |
Rifampin | LC-MS/MS | Human Plasma | 0.1-20 ug/mL | K2 EDTA |
Ritalinic Acid-d; Ritalinic Acid-L | LC-MS/MS | Human Plasma | 5-500 ng/mL | EDTA |
Ritonavir | LC-MS/MS | Human Plasma | 5-1000 ng/mL | Sodium EDTA |
Ropinirole | LC-MS/MS | Human Plasma | 0.05-7.5 ng/mL | EDTA |
Rosiglitazone | LC-MS/MS | Human Plasma | 2.5-500 ng/mL | EDTA |
Rosiglitazone; Desmethylrosiglitazone | LC-MS/MS | Human Plasma | 1-400 ng/mL | EDTA |
Rosuvastatin | LC-MS/MS | Human Plasma | 0.2-100 ng/mL | EDTA |
Rotigotine | LC-MS/MS | Human Plasma | 0.01-2 ng/mL | EDTA |
S-PMA; SBMA | LC-MS/MS | Human Urine | 25-6250 pg/mL; 100-25000 pg/mL | N/A |
SARS-COV-2 | RT-PCR | Nasal Epithelial Cells | N/A | N/A |
SARS-COV-2 | RT-PCR | Nasopharyngeal Cells | N/A | N/A |
Scopolamine | LC-MS/MS | Human Plasma | 5-500 pg/mL | EDTA |
sICAM | ELISA | Human Plasma | 30-400 ng/mL | Heparin |
Sildenafil; Desmethylsildenafil | LC-MS/MS | Human Plasma | 1-400 ng/mL | EDTA |
Simvastatin; Simvastatin Hydroxy Acid | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | EDTA |
Sitagliptin | LC-MS/MS | Human Plasma | 2.5-500 ng/mL | EDTA |
Solifenacin | LC-MS/MS | Human Plasma | 0.1-20 ng/mL | EDTA |
Soluble Leptin Receptor | EIA | Human Plasma | | |
Soluble Leptin Receptor | ELISA | Human Plasma | 8-80 ng/mL | EDTA |
Sumatriptan | LC-MS/MS | Human Plasma | 0.1-15 ng/mL | K2 EDTA |
Sumatriptan | LC-MS/MS | Human Plasma | 0.5-100 ng/mL | K2 EDTA |
Tacrolimus | LC-MS/MS | Human Whole Blood | 0.5-50 ng/mL | K2 EDTA |
Tadalafil | LC-MS/MS | Human Plasma | 1-400 ng/mL | EDTA |
TBNK | | Human Whole Blood | N/A | EDTA |
TBX2 | EIA | Human Plasma | N/A | N/A |
TBX2 | EIA | Human Serum | N/A | N/A |
Telapravir | LC-MS/MS | Human Plasma | 0.1-20 ug/mL | K2 EDTA |
Telmisartan | LC-MS/MS | Human Plasma | 0.5-100 ng/mL | EDTA |
Testosterone; Methyltestosterone | LC-MS/MS | Human Plasma | 0.05-10 ng/mL | N/A |
Thalidomide | LC-MS/MS | Human Plasma | 20-2000 ng/mL | Heparin |
Theophylline | LC-MS/MS | Human Plasma | 100-20000 ng/mL | EDTA |
Tiagabine | LC-MS/MS | Human Plasma | 0.5-200 ng/mL | EDTA |
TNF alpha | EIA | Human Plasma | 1-32 pg/mL | Lithium Heparin |
Tolterodine; 5-Hydroxymethyl Tolterodine | LC-MS/MS | Human Plasma | 15-5000 pg/mL; 15-5000 pg/mL | EDTA |
Topiramate | LC-MS/MS | Human Plasma | 10-1000 ng/mL | EDTA |
Total Antioxidant Capacity (TAC) | ELISA | Human Serum | 100-300 uM | N/A |
Triamcinolone Acetonide | LC-MS/MS | Human Plasma | 50-4000 pg/mL | EDTA |
Valsartan | LC-MS/MS | Human Plasma | 15-7000 ng/mL | EDTA |
Valsartan | LC-MS/MS | Human Serum | 15-7000 ng/mL | N/A |
Verapamil; Norverapamil | LC-MS/MS | Human Plasma | 2.5-250 ng/mL | Heparin |
Verapamil; Norverapamil | LC-MS/MS | Human Plasma | 1.3-250 ng/mL | Heparin |
Voriconazole | LC-MS/MS | Human Plasma | 5-2000 ng/mL | EDTA |
Zidovudine; Abacavir | LC-MS/MS | Human Plasma | 10-3000 ng/mL; 10-3000 ng/mL | EDTA |
Zileuton; A66193 | LC-MS/MS | Human Plasma | 0.05-10 ug/mL | EDTA |
Zinc | ICP/MS | Human Serum | 300-5000 ng/mL | N/A |
Zolpidem | LC-MS/MS | Human Plasma | 1-250 ng/mL | EDTA |
Zonisamide | LC-MS/MS | Human Serum | 30-3000 ng/mL | N/A |